Real-World check: IBRANCE® works as expected in advanced breast cancer
NCT ID NCT03445637
First seen Jan 09, 2026 · Last updated Apr 29, 2026 · Updated 16 times
Summary
This study looked at how safe and effective IBRANCE® is for women with advanced or metastatic breast cancer when used in everyday medical practice. Over 500 women in Korea took part, and researchers tracked side effects and how well the drug controlled the cancer. The goal was to confirm the drug's real-world performance after it was approved for use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.